Evaluation of efficacy of rebamipide ophthalmic suspension in patients with dry eye associated with Sjogren's syndrome.

Not Applicable

• Conditions: Patients with dry eye associated with Sjogren' s syndrome.

• Registration Number: JPRN-UMIN000008427
• Lead Sponsor: Kanazawa Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-07-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with concomitant anterior eye disease other than dry eye. 2.Patients who have used rebamipide ophthalmic suspension within two weeks prior to the start of the study. 3.Patients who are anticipated to change their eye drop (prescription or OTC medication) during the study. 4.Patients who cannot discontinue use of contact lenses during the study. 5.Patients who inserted punctal plugs or underwent surgical punctal occlusion within one month. 6.Patients who are pregnant, suspected to be pregnant or breastfeeding. 7.Patients who are hypersensitive to the ingredients of the study drug and/or test reagents for this study. 8.Patients who are judged to be ineligible for the study for complications and/or history of systemic disease. 9.Patients who are considered to be inapproriate by the investigators.

Study & Design

• Study Type: Interventional
• Study Design: Not specified